AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+36.7%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.37B
AUM Growth
+$4.37B
(+44%)
Cap. Flow
+$620M
Cap. Flow
% of AUM
14.19%
Top 10 Holdings %
Top 10 Hldgs %
43.92%
Holding
157
New
22
Increased
25
Reduced
24
Closed
21
Top Buys
| 1 |
Seer Inc
SEER
|
$328M |
| 2 |
SQZ
SQZ Biotechnologies Company
SQZ
|
$46.6M |
| 3 |
Zillow
Z
|
$45.4M |
| 4 |
IGMS
IGM Biosciences
IGMS
|
$45.1M |
| 5 |
Praxis Precision Medicines
PRAX
|
$41.3M |
Top Sells
| 1 |
BioNTech
BNTX
|
$59.6M |
| 2 |
Alibaba
BABA
|
$52.4M |
| 3 |
Moderna
MRNA
|
$26.1M |
| 4 |
StoneCo
STNE
|
$21.2M |
| 5 |
Scholar Rock
SRRK
|
$19.2M |
Sector Composition
| 1 | Healthcare | 82.45% |
| 2 | Consumer Discretionary | 9.72% |
| 3 | Technology | 2.14% |
| 4 | Communication Services | 1.97% |
| 5 | Real Estate | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXRT
151
DELISTED
Vaxart
VXRT
| – | – | -750,000 | Closed | -$4.99M |
|
152
Energy Select Sector SPDR Fund
XLE
$27.6B
| – | – | 0 | – | – |
|
153
Industrial Select Sector SPDR Fund
XLI
$23.3B
| – | – | 0 | – | – |
|
154
Zentalis Pharmaceuticals
ZNTL
$122M
| – | – | -87,400 | Closed | -$2.86M |
|
|
EPZM
155
DELISTED
Epizyme, Inc
EPZM
| – | – | -1,000,000 | Closed | -$11.9M |
|
|
PAND
156
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| – | – | -145,000 | Closed | -$1.66M |
|
|
PRVL
157
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| – | – | -302,750 | Closed | -$3.08M |
|